Outcomes4Me is a Fast Company World Changing Idea! Learn more >>

for-life-sciences, for-patients, Research Updates, thought leadership, Treatment Options

Newsflash: First Oral SERD Orserdu (elacestrant) FDA-Approved

January 31, 2023

If you were diagnosed with ER-positive, HER2-negative metastatic breast cancer and are now wondering if this new therapy is an option for your cancer, you are not alone! Outcomes4Me has a team of oncology nurse practitioners that would be happy to review your medical records and consult with you. If you have specific questions, please submit them through the app using the AskOutcomes4Me button.

Navigate your cancer journey with confidence

Your cancer experience is unique and so is our app. Here’s why it’s your must-have companion:

Get personalized support and treatment options
Connect with a community of cancer patients and caregivers
Track your symptoms and medications
Access the latest cancer research and clinical trials

Download the Outcomes4Me Cancer Care App

Or use us on the web >>

Related Articles

All About Cancer

The importance of clinical trial research for cancer patients

Clinical trials are essential to advancing cancer treatment. They help researchers discover new therapies, improve...

May 15, 2025

Prostate Cancer

What is the Decipher test and how does it guide prostate cancer treatment?

Understanding the Decipher Prostate test and its role in cancer careHaving an understanding of the...

May 15, 2025

Oral SERD Orserdu is Now FDA Approved